Response to: Correspondence on "Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis" by van Vollenhoven et al

Saved in:

Bibliographic Details
Published in:	Annals of the rheumatic diseases Vol. 82; no. 8; p. e178
Main Authors:	Sparks, Jeffrey A, Wallace, Zachary S, Seet, Andrea M, Robinson, Philip C, Machado, Pedro M, Yazdany, Jinoos
Format:	Journal Article
Language:	English
Published:	England 01-08-2023
Subjects:	Antirheumatic Agents - therapeutic use Arthritis, Rheumatoid - complications Arthritis, Rheumatoid - drug therapy Biological Products - therapeutic use COVID-19 Humans COVID-19 arthritis inflammation rheumatoid
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
ISSN:	1468-2060
DOI:	10.1136/annrheumdis-2021-221157